Sunitinib (Sutent) Plus Nivolumab (Opdivo)

Elodie_Espesset September 15, 2017, 1:56pm 1

Here is a new European clinical trial testing the combination of Sunitinib (multi-targeted RTK inhibitor) with Nivolumab (anti-PD1):

Topic		Replies	Views
Nivolumab and Ipilimumab Phase 2 Trial Clinical Trials and Research Updates	0	2156	August 5, 2017
Nivolumab with or without Votrient (Pazopanib) Clinical Trials and Research Updates	1	2723	July 19, 2017
SBRT and PD-1 or PD-L1 inhibitor Clinical Trials and Research Updates	0	2176	July 19, 2017
Trabectedin Combined with Durvalumab Clinical Trials and Research Updates	0	2101	March 21, 2017
Olaratumab with AIM Clinical Trials and Research Updates	0	1833	September 15, 2017